At a glance
ClinicalIndex Comparison RecordN/ACompleted· 153 enrolled
Drug / intervention
Aurora Endometrial Ablation +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Minerva Pivotal Study
In Brief
A clinical study evaluating Aurora Endometrial Ablation and Rollerball Ablation/Resection for Menorrhagia. Completed, enrolled 153 participants across 13 sites in 3 countries.
Detailed Summary
The primary objective of this study is to evaluate the safety and effectiveness of the Aurora Endometrial Ablation System as compared to hysteroscopic rollerball endometrial ablation in reducing menstrual blood loss at 12 months post-treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMenorrhagia
CountriesCanada, Mexico, United States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2012
First PostedApr 2012
Primary CompletionJan 2015
Study CompletionMar 2018
TodayJul 2026
First PostedApr 3, 2012
Enrollment StartMar 1, 2012
Primary CompletionJan 1, 2015
Study CompletionMar 2, 2018
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 14.2 years ago
Interventions
Aurora Endometrial Ablationdevice
Endometrial Ablation using the Aurora Endometrial Ablation system
Rollerball Ablation/Resectiondevice
Hysteroscopic rollerball resection/ablation